Growth Metrics

Quest Diagnostics (DGX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $142.0 million.

  • Quest Diagnostics' Depreciation & Amortization (CF) rose 1360.0% to $142.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $560.0 million, marking a year-over-year increase of 1991.43%. This contributed to the annual value of $493.0 million for FY2024, which is 1230.07% up from last year.
  • Latest data reveals that Quest Diagnostics reported Depreciation & Amortization (CF) of $142.0 million as of Q3 2025, which was up 1360.0% from $143.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Depreciation & Amortization (CF) registered a high of $143.0 million during Q2 2025, and its lowest value of $100.0 million during Q2 2021.
  • In the last 5 years, Quest Diagnostics' Depreciation & Amortization (CF) had a median value of $111.0 million in 2023 and averaged $115.9 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first tumbled by 603.45% in 2023, then surged by 2385.32% in 2024.
  • Quest Diagnostics' Depreciation & Amortization (CF) (Quarter) stood at $106.0 million in 2021, then rose by 9.43% to $116.0 million in 2022, then decreased by 6.03% to $109.0 million in 2023, then grew by 23.85% to $135.0 million in 2024, then rose by 5.19% to $142.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $142.0 million in Q3 2025, compared to $143.0 million in Q2 2025 and $140.0 million in Q1 2025.